You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydrocodone Bitartrate And Homatropine Methylbromide, and when can generic versions of Hydrocodone Bitartrate And Homatropine Methylbromide launch?

Hydrocodone Bitartrate And Homatropine Methylbromide is a drug marketed by Abhai Llc, Actavis Mid Atlantic, Apozeal Pharms, Genus, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, and Wockhardt Bio Ag. and is included in nine NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocodone Bitartrate And Homatropine Methylbromide

A generic version of HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
  • What are the global sales for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
  • What is Average Wholesale Price for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
Summary for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Drug patent expirations by year for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Pharmacology for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abhai Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 207487-001 Feb 21, 2017 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novel Labs Inc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 203535-001 Feb 13, 2017 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Genus HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040613-001 Feb 8, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 205731-001 Feb 15, 2017 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Mid Atlantic HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 088017-001 Jul 5, 1983 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apozeal Pharms HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 204765-001 Mar 6, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Nostrum Labs Inc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 210663-001 Jun 11, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.